Product
N9-GP
1 clinical trial
2 indications
Indication
Congenital Bleeding DisorderIndication
Hemophilia BClinical trial
A Trial Comparing the Pharmacokinetics of Nonacog Beta Pegol (N9-GP) and ALPROLIX® in Patients With Haemophilia BStatus: Completed, Estimated PCD: 2017-12-08